Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
---|
01/19/1993 | US5180824 Preparation of 2-fluoroadenine, fludarabine or fuldarabine phosphate |
01/19/1993 | US5180714 Adenosine compounds for the treatment of diseases caused by parasitic protozoa |
01/13/1993 | EP0521941A1 Cmp-activated fluorescent sialinic acids and process for producing them |
01/13/1993 | EP0275249B1 Continuous intravenous infusion of adenosine to human patients, a unit dosage form of adenosine and use of adenosine for the manufacture of medicaments |
01/12/1993 | US5179200 Nucleosides |
01/12/1993 | US5179087 Antibody inhibitors |
01/12/1993 | US5179084 Antiviral phosphoric acid esters of oxetanocins |
01/12/1993 | CA1312599C 2',3'dideoxy-2',2'difluoronucleosides |
01/07/1993 | WO1993000444A1 Biotinylated photoaffinity nucleotide analogues - synthesis and application |
01/07/1993 | EP0418309A4 Oligonucleotide analogs containing sulfur |
01/06/1993 | CN1067654A Processes for diastereoselective synthesis of nucleosides |
01/05/1993 | US5177196 Used for diagnostic and chemotherapeutic purposes |
01/05/1993 | US5177064 Targeted drug delivery via phosphonate derivatives |
01/05/1993 | US5177063 Avermectin compounds with a 6,5-spiroketal ring system |
12/30/1992 | EP0520557A1 A process for the glycosylation of avermectin compounds |
12/30/1992 | EP0520552A1 Derivatives of (hetero) aromatic ethers and thioethers having antihyperlipidemic activity, process for their preparation and pharmaceutical compositions containing them |
12/29/1992 | US5175291 Reaction of 1,4-dioxaspiro 4,4!nonan-7-carboxylic acid with carbonyldiimidazole with 5,6-diamino-1,3-dipropyluracil in the presence of calcium hydroxide and hydroxylating |
12/29/1992 | US5175274 Therapeutic nucleosides |
12/29/1992 | US5175273 Pyridinone or pyrimidinone nucleoside bases containing fused aromatic polycyclic rings |
12/29/1992 | US5175267 Reacting with a silyl halide to form a silyl enol ether, reaction with a selenenyl halide and reduction to furanose and condensing with a heterocyclic base |
12/29/1992 | US5175266 Oxidizing hydroxymethyl function of azidodeoxynucleosides to acid in presence of ruthenium tetroxide |
12/27/1992 | CA2071574A1 Process for the glycosylation of avermectin compounds |
12/23/1992 | WO1992022662A1 Methods for the synthesis of monofucosylated oligosaccharides terminating in di-n-acetyllactosaminyl structures |
12/23/1992 | WO1992022661A1 Methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides |
12/23/1992 | WO1992022565A1 Modified sialyl lewisx compounds |
12/23/1992 | WO1992022564A1 Immunosuppressive and tolerogenic modified lewisx and lewisa compounds |
12/23/1992 | WO1992022563A1 Modified sialyl lewisa compounds |
12/23/1992 | WO1992022548A1 PROCESS FOR PRODUCING 2',3'-DIDEOXY-β-NUCLEOSIDE |
12/23/1992 | WO1992022301A1 Immunosuppressive and tolerogenic oligosaccharide derivatives |
12/23/1992 | EP0519731A1 4a-Substituted avermectin derivatives |
12/23/1992 | EP0519464A1 Nucleoside derivatives and production thereof |
12/23/1992 | CN1067245A Processes for diastereoselective synthesis of nucleosides |
12/23/1992 | CA2110997A1 Methods for the synthesis of monofucosylated oligosaccharides terminating in di-n-acetyllactosaminyl structures |
12/23/1992 | CA2110707A1 Immunosuppressive and tolerogenic oligosaccharide modified lewis x and lewis a compounds |
12/23/1992 | CA2110495A1 Immunosuppressive and tolerogenic oligosaccharide derivatives |
12/22/1992 | WO1993000351A1 Novel anti-viral compounds and processes for production of anti-viral compounds |
12/22/1992 | CA2158009A1 Anti-viral compounds and processes for production of anti-viral compounds |
12/22/1992 | CA2071690A1 Derivatives of (hetero) aromatic ethers and thioethers having antihyperlipidemic activity, process for their preparation and pharmaceutical compositions containing them |
12/21/1992 | CA2071803A1 4a-substituted avermectin derivatives |
12/17/1992 | DE4119075A1 New nucleoside tri:phosphoric acid ester derivs. - used for prepn. of polymerase chain reaction probes, amplification of nucleic acid sequences and as chain terminators for sequences |
12/16/1992 | EP0517796A1 Oligonucleotide analogs. |
12/16/1992 | CN1019495B Preparation for pyrimidine derivative |
12/15/1992 | US5171849 2' and 3' Carboranyl uridines and their diethyl ether adducts |
12/15/1992 | CA1311428C Deoxyribonucleoside phosphoramidites in which an aliphatic amino group is attached to the sugar ring and their use for the preparation of oligonucleotides containing aliphatic amino groups, fluorescent dyes, and other detectable moieties |
12/10/1992 | WO1992021692A1 Oligo-2'-deoxynucleotides and their use as drugs with an antiviral action |
12/10/1992 | WO1992021688A1 New perfluoroalkylated amphiphilic phosphorus compounds: preparation and biomedical applications |
12/10/1992 | WO1992021343A1 Novel pyrazinone n-oxide nucleosides and analogs thereof |
12/10/1992 | WO1992021337A1 Methods of treating injury to the central nervous system |
12/10/1992 | WO1992004359A3 Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof |
12/09/1992 | EP0517573A1 Pharmaceutical compositions for the treatment of airway disorders |
12/09/1992 | EP0517262A1 Trifluorothymidine derivatives, process for producing the same and anti-cancer agent containing the same |
12/09/1992 | EP0516851A1 Physiologically active substance well capable of permeating biomembrane |
12/08/1992 | WO1992021689A1 Silyl phosphorylating reagents and methods of using them |
12/08/1992 | US5169956 Macrolide antibiotic compounds |
12/08/1992 | US5169851 Administering for fungal infections in mammals |
12/08/1992 | US5169839 Pesticides for animals and plants |
12/08/1992 | US5169778 Culture which produces insecticidal enzyme inhibitor for glucohydrolases |
12/08/1992 | CA2107911A1 Silyl phosphorylating reagents and methods of using them |
12/08/1992 | CA1311201C Desazapurine-nucleoside derivatives, processes for the preparation thereof, pharmaceutical compositions containing them and the use thereof fornucleic acid sequencing and as antiviral agents |
12/06/1992 | WO1992021690A1 Purine base modified 2'-deoxyribonucleosides, use in triplex forming oligonucleotides and process for preparing the same |
12/06/1992 | CA2088787A1 Purine base modified 2'-deoxyribonucleosides, use in triplex forming oligonucleotides and process for preparing the same |
12/02/1992 | EP0516186A2 Nucleosides and nucleoside analogues, pharmaceutical composition and processes for the preparation of the compounds |
12/02/1992 | EP0515514A1 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents |
12/02/1992 | CN1019302B Polycyclic ether antibioties |
12/01/1992 | WO1992021352A1 USE OF 1-(β-D-ARABINOFURANOSYL)-5-PROPYNYLURACIL FOR LOWERING SERUM CHOLESTEROL |
12/01/1992 | CA2088264A1 Nucleoside derivative |
11/26/1992 | WO1992020823A1 Backbone modified oligonucleotide analogs |
11/26/1992 | WO1992020822A1 Backbone modified oligonucleotide analogues |
11/26/1992 | WO1992020816A1 Determination of prodrugs metabolizable by the liver and therapeutic use thereof |
11/26/1992 | WO1992020696A1 Processes for the diastereoselective synthesis of nucleosides |
11/26/1992 | WO1992020669A1 Processes for the diastereoselective synthesis of nucleosides |
11/26/1992 | WO1992020646A1 Novel quaternary ammonium salts, process for obtaining same and pharmaceutical compositions containing them |
11/26/1992 | WO1992020347A1 2'-fluoro-2-substituted adeninyl arabinosides as anti-cancer agents |
11/26/1992 | WO1992020336A2 Novel cholesterol lowering compounds |
11/26/1992 | DE4117186A1 Oligo-2'-desoxynukleotide und ihre verwendung als arzneimittel mit antiviraler wirksamkeit Oligo-2'-deoxynucleotides and their use as medicaments having antiviral efficacy |
11/26/1992 | CA2109523A1 Novel cholesterol lowering compounds |
11/26/1992 | CA2103378A1 Backbone modified oligonucleotide analogues |
11/26/1992 | CA2103050A1 Determination of prodrugs metabolizable by the liver and therapeutic use thereof |
11/25/1992 | EP0515157A1 Processes for the diastereoselective synthesis of nucleosides |
11/25/1992 | EP0515156A1 Processes for the diastereo-selective synthesis of nucleosides |
11/25/1992 | EP0514568A1 Antiprotozoal compositions containing 2-nitroimidazole derivatives |
11/25/1992 | EP0514513A1 Method and means for oligonucleotide synthesis. |
11/25/1992 | EP0248084B1 Modulation of animal cellular responses with compositions containing isoxanthopterin-8-(1'-beta-aldoglycosidyl) derivatives |
11/24/1992 | US5166330 Process for the preparation of nucleoside alkyl-aralkyl- and aryl-phosphonites and -phosphonates |
11/24/1992 | US5166328 Antiischemic agents and nervous system disorders |
11/24/1992 | US5166327 Acetylation of 3'-deoxy-3'-fluoro-5'-mesylthymidine and deacetylation |
11/24/1992 | US5166141 Antigen specific immunune response by contacting lymphocytes |
11/24/1992 | US5165231 Anti-reversion exhaust system |
11/23/1992 | WO1992020346A1 Method and composition to reduce myocardial reperfusion injury |
11/22/1992 | CA2103464A1 Backbone modified oligonucleotide analogs |
11/19/1992 | EP0514090A1 Procedure for the inversion of the stereochemistry at C13 of avermectin aglycone compounds |
11/19/1992 | EP0514036A2 Preparation of thionucleosides |
11/19/1992 | EP0513200A1 Method and compositions for the synthesis of bch-189 and related compounds |
11/19/1992 | EP0513067A1 A pratical synthesis of 2'-deoxynucleosides and 2',3'-dideoxy-2',3'-didehydronucleosides |
11/17/1992 | US5164500 Viricides |
11/17/1992 | US5164491 High efficiency |
11/17/1992 | CA2087158A1 Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses |
11/14/1992 | CA2068388A1 Procedure for the inversion of the sterochemistry at c13 of avermectin aglycone compounds |
11/12/1992 | WO1992019637A1 Oligonucleotide analogs containing thioformacetal linkages |
11/12/1992 | WO1992019278A1 Use of macrolide compounds for eye diseases |